AZR

3.7552.97%
JS

Julie Saiki

Co-Founder, Treasurer, Secretary & Director

Dr. Julie Saiki, Ph.D., was Executive Vice President of Strategy of Adial Pharmaceuticals, Inc. from June 2026 to October 28, 2026. Dr. Saiki is Chief Strategy Officer of Adial Pharmaceuticals, Inc. from October 28, 2026. She is Co-Founder of Azora Therapeutics, Inc. and serves as its Treasurer, Secretary and Director and served as its Chief Operating Officer. Dr. Saiki was a consultant at McKinsey & Company, where she advised pharmaceutical and biotechnology companies on strategy and operations spanning research and development and commercial functions. Dr. Saiki is an experienced biotechnology executive with expertise bringing novel therapeutics from early-stage research into clinical development. She previously served as Co-founder and Chief Operating Officer at Legacy Azora, where she advanced multiple preclinical assets into clinical-stage development. Prior to her role at Legacy Azora, she worked as a management consultant at McKinsey and Company where she advised biopharmaceutical companies on strategy and operations. She holds an M.S. in Medicine and a Ph.D. in Chemical and Systems Biology from Stanford University.

Positions